Gene Therapy for Aromatic l -Amino Acid Decarboxylase Deficiency
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Aromatic L-amino acid decarboxylase (AADC) is required for the synthesis of the neurotransmitters dopamine and serotonin. Children with defects in the AADC gene show compromised development, particularly in motor function. Drug therapy has only marginal effects on some of the symptoms and does not change early childhood mortality. Here, we performed adeno-associated viral vector-mediated gene transfer of the human AADC gene bilaterally into the putamen of four patients 4 to 6 years of age. All of the patients showed improvements in motor performance: One patient was able to stand 16 months after gene transfer, and the other three patients achieved supported sitting 6 to 15 months after gene transfer. Choreic dyskinesia was observed in all patients, but this resolved after several months. Positron emission tomography revealed increased uptake by the putamen of 6-[(18)F]fluorodopa, a tracer for AADC. Cerebrospinal fluid analysis showed increased dopamine and serotonin levels after gene transfer. Thus, gene therapy targeting primary AADC deficiency is well tolerated and leads to improved motor function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals typically die by the age of 5 years old.59”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [59]
Citations
Cites
Shohamy, D., & Adcock, R. A. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.08.002 · Cited by 707 · cited 1×
“For example, recent findings indicate that dopamine modulates the hippocampus, which is a crucial brain system for achieving long-term memory (22).”
ResultMarks, W. J., Bartus, R. T., Siffert, J., Davis, C. S., Lozano, A., Boulis, N., Vitek, J., Stacy, M., Turner, D., Verhagen, L., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70254-4 · Cited by 684
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's disease
Obeso, J. A., Rodríguez-Oroz, M. C., Benitez-Temino, B., Blesa, F. J., Guridi, J., Marin, C., & Rodriguez, M. (2008) · Movement Disorders · doi:10.1002/mds.22062 · Cited by 663
Imaging brain plasticity during motor skill learning
Ungerleider, L. (2002) · Neurobiology of Learning and Memory · doi:10.1006/nlme.2002.4091 · Cited by 641 · cited 1×
“Human novel motor training stimulates a slow reorganization of the primary motor cortex, striatum, and other motor-related areas, as shown by functional MRI studies (16).”
BackgroundFrank, M. J., & O'Reilly, R. C. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.3.497 · Cited by 472
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c29356 · Cited by 445 · cited 1×
“Recently, two phase 1 clinical studies using gene therapy in Parkinson’s disease have shown that the adeno-associated virus (AAV) type 2 vector– mediated delivery of the human AADC gene (AAV2-hAADC) into the putamen is safe and well tolerated in adults (8, 9).”
BackgroundA phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson’s disease
Muramatsu, S.-I., Fujimoto, K.-I., Kato, S., Mizukami, H., Asari, S., Ikeguchi, K., Kawakami, T., Urabe, M., Kume, A., Sato, T., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.135 · Cited by 344 · cited 2×
“Recently, two phase 1 clinical studies using gene therapy in Parkinson’s disease have shown that the adeno-associated virus (AAV) type 2 vector– mediated delivery of the human AADC gene (AAV2-hAADC) into the putamen is safe and well tolerated in adults (8, 9).”
BackgroundSelf-citationLong-Term Clinical Improvement in MPTP-Lesioned Primates after Gene Therapy with AAV-hAADC
Bankiewicz, K. S., Forsayeth, J., Eberling, J. L., Sanchez-Pernaute, R., Pivirotto, P., Bringas, J., Herscovitch, P., Carson, R. E., Eckelman, W., Reutter, B., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.005 · Cited by 282 · cited 1×
“The retrograde transport of AAV2 vectors is rare in mammalian brains, and most of the transduced cells in the putamen in a primate model of Parkinson’s disease are likely to be medium spiny neurons (12, 13), which are assumed to sequester abundant L-DOPA and to produce dopamine.”
BackgroundClinical and biochemical features of aromatic L-amino acid decarboxylase deficiency
Brun, L., Ngu, L. H., Keng, W. T., Ch'ng, G. S., Choy, Y. S., Hwu, W. L., Lee, W. T., Willemsen, M. A. A. P., Verbeek, M. M., Wassenberg, T., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e620ae · Cited by 226 · cited 4×
“Case number in (5) 43 40 42 Not described”
BackgroundInfluentialSelf-citationSensitive periods in human development: Evidence from musical training
Penhune, V. B. (2011) · Cortex · doi:10.1016/j.cortex.2011.05.010 · Cited by 198
Muramatsu, S.-I., Fujimoto, K.-I., Ikeguchi, K., Shizuma, N., Kawasaki, K., Ono, F., Shen, Y., Wang, L., Mizukami, H., Kume, A., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340252792486 · Cited by 187 · cited 1×
“The retrograde transport of AAV2 vectors is rare in mammalian brains, and most of the transduced cells in the putamen in a primate model of Parkinson’s disease are likely to be medium spiny neurons (12, 13), which are assumed to sequester abundant L-DOPA and to produce dopamine.”
BackgroundSelf-citationPhD, K. H., Surtees, R. A. H., MD, C. R., & Clayton, P. T. (1992) · Neurology · doi:10.1212/wnl.42.10.1980 · Cited by 176
The role of serotonin in respiratory function and dysfunction
Hilaire, G., Voituron, N., Menuet, C., Ichiyama, R. M., Subramanian, H. H., & Dutschmann, M. (2010) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2010.08.017 · Cited by 172
Changes in the neural control of a complex motor sequence during learning
Ölveczky, B. P., Otchy, T. M., Goldberg, J. H., Aronov, D., & Fee, M. S. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00018.2011 · Cited by 136 · cited 1×
“The acquisition of complex motor sequences may need to be achieved through prolonged experience by the patient (18).”
BackgroundAromatic amino acid decarboxylase deficiency in twins
Hyland, Κ., & Clayton, P. T. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799380 · Cited by 123 · cited 1×
“AADC deficiency [Mendelian Inheritance in Man (MIM) 608643] was first identified in 1990 by screening the cerebrospinal fluid (CSF) of children with unidentified neurological disorders (3, 4).”
BackgroundAromatic l ‐amino acid decarboxylase deficiency: clinical features, drug therapy and follow‐up
Manegold, C., Hoffmann, G. F., Degen, I., Ikonomidou, H., Knust, A., Laass, M. W., Pritsch, M., Wilichowski, E., & Hörster, F. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1076-1 · Cited by 116
AromaticL-amino acid decarboxylase deficiency: Overview of clinical features and outcomes
Swoboda, K. J., Saul, J. P., McKenna, C. E., Speller, N. B., & Hyland, K. (2003) · Annals of Neurology · doi:10.1002/ana.10631 · Cited by 111
Aromatic l-amino acid decarboxylase deficiency in Taiwan
Lee, H.-F., Tsai, C., Chi, C.-S., Chang, T., & Lee, H. (2008) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.03.008 · Cited by 89
Normal sexual dimorphism in the human basal ganglia
Rijpkema, M., Everaerd, D., van der Pol, C., Franke, B., Tendolkar, I., & Fernández, G. (2012) · Human Brain Mapping · doi:10.1002/hbm.21283 · Cited by 85 · cited 1×
“of putamen in normal adults is about 10 ml (20), and the putamen sizes of our patients, who were 4 to 5 years of age, were very close to adult volumes.”
BackgroundA new perspective on the treatment of aromatic l-amino acid decarboxylase deficiency
Allen, G. F. G., Land, J. M., & Heales, S. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.01.010 · Cited by 69 · cited 1×
“Because the main symptoms of AADC deficiency include motor impairment, it has been suggested that the disease is a promising candidate for a similar gene therapy approach (10).”
BackgroundUnusually mild phenotype of AADC deficiency in 2 siblings
Tay, S. K. H., Poh, K. S. L., Hyland, Κ., Pang, Y. W., Ong, H. T., Low, P. S., & Goh, D. L. M. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.04.006 · Cited by 54 · cited 2×
“%) in Taiwanese patients with AADC deficiency carried the IVS6+4 A>T mutation (7).”
BackgroundLiao, H., Yao, G., & Wang, T.-M. (2008) · Perceptual and Motor Skills · doi:10.2466/pms.107.1.29-44 · Cited by 32 · cited 1×
“Developmental evaluation The AIMS, PDMS-II, and CDIIT scales (25) were used to evaluate the motor development of the patients.”
MethodIto, T., Yamamoto, S., Hayashi, T., Kodera, M., Mizukami, H., Ozawa, K., & Muramatsu, S.-I. (2009) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009077 · Cited by 24
Self-citationSoiza‐Reilly, M., & Azcurra, J. M. (2009) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2009.03.001 · Cited by 23 · cited 1×
“We were concerned that the subjects selected for this study were beyond the natural critical period for activity-dependent plasticity that has been well described in animal models (15, 17).”
ResultIbarra, G. R., Paratcha, G., Wolansky, M. J., & Azcurra, J. M. (1996) · Neuroreport · doi:10.1097/00001756-199611040-00018 · Cited by 15
Production of research and clinical‐grade recombinant adeno‐associated virus vectors
Francis, J. D., & Snyder, R. O. (2005) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(05)31002-3 · Cited by 6
Self-citationCPP antagonizes hypoxia-induced changes in dopamine metabolism in the striatum of newborn rat
Kuo, M., Wu, R., Wang, H.-S., & Lin, S.-M. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(99)00084-x · Cited by 4 · cited 2×
“We also measured the L-DOPA levels in the CSF by HPLC (26).”
MethodSelf-citation
Research works printed but not linked: 1
- J. D. Francis R. O. Snyder in Laboratory Techniques in Biochemistry and Molecular Biology K. I. Berns T. R. Flotte Eds. (Elsevier Amsterdam 2005) vol. 31 pp. 19–56.
Cited by
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
Adeno-associated virus as a delivery vector for gene therapy of human diseases
Wang, J.-H., Gessler, D. J., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01780-w · Cited by 904
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743
Self-citationTherapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
Hudry, E., & Vandenberghe, L. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.017 · Cited by 369
In vivo tissue-tropism of adeno-associated viral vectors
Srivastava, A. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.08.003 · Cited by 347
Metadata
- Authors
- Hwu, W.-L., Muramatsu, S.-I., Tseng, S.-H., Tzen, K.-Y., Lee, N.-C., Chien, Y.-H., Snyder, R. O., Byrne, B. J., Tai, C.-H., & Wu, R.-M.
- Affiliations
- National Taiwan University (TW)
- Jichi Medical University (JP)
- University of Florida Health (US)
- University of Florida (US)
- Corresponding author
- Hwu, Wuh-Liang
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2012-05-16
- Volume
- 4
- Issue
- 134
- Pages
- 134ra61-134ra61
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2075622358
- Cited by
- 246
- References
- 27
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 18 · 2023: 22 · 2022: 17 · 2021: 22 · 2020: 25 · 2019: 16 · 2018: 17 · 2017: 15 · 2016: 18 · 2015: 9 · 2014: 21 · 2013: 10 · 2012: 6
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23590473)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- aromatic L-amino acid decarboxylase deficiency, gene therapy, adeno-associated virus vectors, putamen, motor function, dopamine, serotonin, pediatric patients, neurodegeneration
- MeSH terms
- Dependovirus, Amino Acid Metabolism, Inborn Errors, Antibodies, Aromatic-L-Amino-Acid Decarboxylases, Child, Child, Preschool, Demography, Dihydroxyphenylalanine, Female, Genetic Vectors, Humans, Male, Motor Activity, Taiwan, Genetic Therapy, Gene Transfer Techniques, Neurotransmitter Agents, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.